Pop Pulse News

FY2024 Earnings Estimate for Envista Issued By William Blair


FY2024 Earnings Estimate for Envista Issued By William Blair

Envista Holdings Co. (NYSE:NVST - Free Report) - Research analysts at William Blair boosted their FY2024 earnings per share estimates for Envista in a research report issued on Thursday, October 31st. William Blair analyst B. Vazquez now anticipates that the company will earn $0.77 per share for the year, up from their prior estimate of $0.71. The consensus estimate for Envista's current full-year earnings is $0.70 per share. William Blair also issued estimates for Envista's Q1 2025 earnings at $0.27 EPS, Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.27 EPS, Q4 2025 earnings at $0.33 EPS, FY2025 earnings at $1.17 EPS and FY2026 earnings at $1.35 EPS.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.03. The business had revenue of $601.00 million during the quarter, compared to analysts' expectations of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The business's quarterly revenue was down 4.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.43 EPS.

A number of other analysts also recently issued reports on NVST. Evercore ISI lifted their price target on Envista from $18.00 to $23.00 and gave the stock an "outperform" rating in a report on Monday, September 23rd. Piper Sandler upped their price target on Envista from $16.00 to $17.00 and gave the company a "neutral" rating in a report on Thursday. Needham & Company LLC reissued a "hold" rating on shares of Envista in a report on Thursday. Stifel Nicolaus upped their target price on shares of Envista from $18.00 to $21.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Finally, Leerink Partners upgraded shares of Envista from an "underperform" rating to a "market perform" rating and lifted their price target for the stock from $16.00 to $23.00 in a research note on Thursday. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, Envista presently has an average rating of "Hold" and a consensus price target of $20.71.

Read Our Latest Stock Analysis on Envista

Shares of NVST opened at $20.94 on Monday. The firm has a market capitalization of $3.60 billion, a price-to-earnings ratio of -2.69 and a beta of 1.30. The firm's fifty day simple moving average is $18.64 and its 200-day simple moving average is $18.05. Envista has a twelve month low of $15.15 and a twelve month high of $25.64. The company has a current ratio of 2.08, a quick ratio of 1.90 and a debt-to-equity ratio of 0.42.

Hedge funds have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Envista during the 3rd quarter worth approximately $31,000. GAMMA Investing LLC boosted its position in shares of Envista by 69.8% during the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock worth $35,000 after purchasing an additional 726 shares in the last quarter. Blue Trust Inc. grew its stake in shares of Envista by 69.7% during the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock worth $39,000 after purchasing an additional 804 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock valued at $43,000 after purchasing an additional 728 shares in the last quarter. Finally, Versant Capital Management Inc lifted its stake in shares of Envista by 1,420.3% in the second quarter. Versant Capital Management Inc now owns 3,147 shares of the company's stock valued at $52,000 after purchasing an additional 2,940 shares during the period.

In related news, CFO Eric D. Hammes purchased 24,532 shares of the firm's stock in a transaction that occurred on Monday, August 12th. The stock was purchased at an average cost of $16.33 per share, with a total value of $400,607.56. Following the completion of the acquisition, the chief financial officer now directly owns 24,532 shares in the company, valued at $400,607.56. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 1.30% of the company's stock.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY

corporate

7792

tech

8851

entertainment

9715

research

4196

wellness

7541

athletics

9963